Gestational Diabetes But Not Prepregnancy Overweight Predicts for Cardiometabolic Markers in Offspring Twenty Years Later

J Clin Endocrinol Metab. 2019 Jul 1;104(7):2785-2795. doi: 10.1210/jc.2018-02743.

Abstract

Context: Maternal gestational diabetes mellitus (GDM) and prepregnancy overweight/obesity [body mass index (BMI) ≥25 kg/m2] might adversely affect offspring cardiometabolic health.

Objective: To assess the associations between maternal GDM and prepregnancy overweight/obesity with adult offspring cardiometabolic risk factors.

Design: Longitudinal cohort study (ESTER Maternal Pregnancy Disorders Study and the Arvo Ylppö Longitudinal Study).

Setting: Province of Uusimaa and Northern Finland.

Participants: At a mean age of 24.1 ± 1.3 years, we classified offspring as offspring of mothers with GDM regardless of the prepregnancy BMI (OGDM; n = 193); normoglycemic mothers with prepregnancy overweight/obesity (ONO; n = 157); and normoglycemic mothers with prepregnancy BMI <25 kg/m2 (controls; n = 556).

Main outcome measures: We assessed the cardiometabolic biomarkers from blood and measured the blood pressure at rest and heart rate.

Results: Compared with the controls, the OGDM and ONO groups had greater fasting glucose (1.6%; 95% CI, 0.1% to 3.1%; and 2.3%; 95% CI, 0.5% to 4.3%, respectively) and insulin (12.7%; 95% CI, 4.4% to 21.9%; and 8.7%; 95% CI, 0.2% to 17.8%). These differences attenuated to nonsignificance when adjusted for confounders and/or current offspring characteristics, including BMI or body fat percentage. The OGDM group had lower SHBG (men, -12.4%; 95% CI, -20.2% to -3.9%; women, -33.2%; 95% CI, -46.3% to -16.8%), high-density lipoprotein (-6.6%; 95% CI, -10.9% to -2.2%), and apolipoprotein A1 (-4.5%; 95% CI, -7.5% to -1.4%). These differences survived the adjustments. The heart rate and other biomarkers were similar among the groups.

Conclusions: Adult offspring of mothers with GDM have increased markers of insulin resistance and a more atherogenic lipid profile. These were only partly explained by confounders or current offspring adiposity. Maternal prepregnancy overweight/obesity was associated with impaired offspring glucose regulation, which was explained by confounders and/or current adiposity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apolipoprotein A-I / metabolism
  • Apolipoproteins B / metabolism
  • Biomarkers
  • Blood Glucose / metabolism
  • Blood Pressure
  • Cardiovascular Diseases / metabolism*
  • Cholesterol, HDL / metabolism
  • Cholesterol, LDL / metabolism
  • Cohort Studies
  • Diabetes, Gestational / epidemiology*
  • Female
  • Finland / epidemiology
  • Heart Rate
  • Humans
  • Insulin / metabolism
  • Insulin Resistance
  • Longitudinal Studies
  • Male
  • Metabolic Syndrome / metabolism*
  • Obesity, Maternal / epidemiology*
  • Pregnancy
  • Prenatal Exposure Delayed Effects / epidemiology
  • Prenatal Exposure Delayed Effects / metabolism*
  • Sex Hormone-Binding Globulin / metabolism
  • Triglycerides / metabolism
  • Young Adult

Substances

  • Apolipoprotein A-I
  • Apolipoproteins B
  • Biomarkers
  • Blood Glucose
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Insulin
  • Sex Hormone-Binding Globulin
  • Triglycerides